VASCURE FOR VASCULAR REPAIR
Report
- Report Number
- 3005619880-2019-00011
- Event Type
- Injury
- Date Received
- November 13, 2019
- Date of Event
- September 14, 2019
- Report Date
- November 12, 2019
- Manufacturer
- AZIYO BIOLOGICS, INC.
- Product Code
- DXZ
- UDI-DI
- 00859389005140
- PMA / PMN Number
- K140789
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- KY, US
- Reporter Occupation
- PHYSICIAN
Narratives
MANUFACTURING REVIEW OF THE DEVICE HISTORY RECORD FOR THE REPORTED LOT SHOWS ALL UNITS WERE QUALITY RELEASED ON 07 MAY 2019 HAVING MET ALL INTERNAL QC ACCEPTANCE REQUIREMENTS. THERE WERE NO NONCONFORMANCES ASSOCIATED WITH THE MANUFACTURING LOT DURING PRODUCTION AND FINAL PACKAGING. OEM SUPPLIER REVIEWED THE SUB-LOTS ASSOCIATED WITH THE REPORTED LOT AND CONFIRMED THAT "ALL DEVICES MET SPECIFICATION". THE EXACT ROOT CAUSE OF THE EVENT CANNOT BE CONCLUSIVELY DETERMINED. THE PROBABLE CAUSE OF THE EVENT IS PREVIOUS INFECTION AND THE DEVICE MAY NOT HAVE BEEN SEWN TO VIABLE TISSUE.
THE PATIENT WAS ADMITTED TO THE OR FOR A RE-DO ON AN INFECTED ENDARTERECTOMY. BOVINE PATCH WAS EXPLANTED AND REPLACED USING AZIYO VASCURE ON (B)(6) 2019. BOTH THE BOVINE PATCH, FEMORAL ARTERY, BYPASS GRAPH AND SURROUNDING TISSUE OF THE GROIN WERE BADLY INFECTED. IT WAS REPORTED THAT ON (B)(6) 2019 THE VASCURE PATCH HAD DISINTEGRATED/DISSOLVED, FEMORAL ARTERY HAD THROMBOSED AND INFECTION WAS PRESENT. SERRATIA MARCESCENS WAS THE CONFIRMED PATHOGEN. THE SERRATIA MARCESCENS PATHOGEN HAS BEEN PRESENT MULTIPLE TIMES (THE PATIENT WAS GROWING IT WHEN THE VASCURE WAS IMPLANTED) WITH THIS PATIENT AND THE PATIENT'S PREVIOUS HISTORY. THE PHYSICIAN WAS NOT SURE IF THE VASCURE PATCH WAS SEWN TO VIABLE TISSUE AND THAT THIS COULD HAVE CONTRIBUTED TO THE ADVERSE EVENT. THE PATIENT WAS REPORTED AS STABLE AND HEALING.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1110056 | VASCURE FOR VASCULAR REPAIR | VASCURE FOR VASCULAR REPAIR | DXZ | AZIYO BIOLOGICS, INC. | CMCV-013-609 | M19E1184 | 00859389005140 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |